An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
- Published Article
Chinese medical journal
- Publication Date
Dec 01, 2002
Sustained HBV replication and clinical improvement could be obtained by the long-term lamivudine therapy with good tolerance and safety.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/12622930